Existing Heart Failure Drug May Treat Potential COVID-19 Long-Hauler Symptom
UC San Diego clinical trial suggests ivabradine may be effective in treating postural orthostatic tachycardia syndrome, a potential COVID-19 long-hauler symptom.
UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.